99mTc-MAG3: Review of pharmacokinetics, clinical application to renal diseases and quantification of renal function

K Itoh - Annals of nuclear medicine, 2001 - Springer
About 14 years have passed since Fritzberg et al. developed 99m Tc-MAG3 in 1986. The
biological properties of this radiopharmaceutical are somewhat different from radioiodine …

Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques)

EV Dubovsky, CD Russell, A Bischof-Delaloye… - Seminars in nuclear …, 1999 - Elsevier
Comprehensive evaluation of renal transplants has been important in differential diagnosis
of medical and surgical complications in the early post-transplantation period and in the long …

Acute renal infarction: a 10‐year experience

SH Tsai, SJ Chu, SJ Chen, YM Fan… - … journal of clinical …, 2007 - Wiley Online Library
The diagnosis of acute renal infarction (ARI) is often delayed or unrecognised because of its
non‐specific presentation and the rarity of the disease. We evaluated the clinical …

First experience in healthy volunteers with technetium-99m l,l-ethylenedicysteine, a new renal imaging agent

CG Van Nerom, GM Bormans, MJ De Roo… - European journal of …, 1993 - Springer
Animal studies have indicated that technetium-99m l, l-ethylenedicysteine (99m Tc-l, l-EC)
may be a promising tracer agent for renal function studies. We have performed a paired …

Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle

B Bubeck - Seminars in nuclear medicine, 1993 - Elsevier
A sufficiently accurate quantification of renal function requiring only one plasma sample
without an additional gamma camera study has until now only been possible in adults. A …

Measurement of renal function with technetium-99m-MAG3 in children and adults

CD Russell, AT Taylor… - The Journal of Nuclear …, 1996 - search.proquest.com
relevant for the interpretation of "" ln-pentetreotide studies in Page 1 therapy. In addition. the
findings of this study may also be relevant for the interpretation of "" ln-pentetreotide studies in …

Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.

L Kabasakal, HT Turoğlu, C Onsel, K Ozker… - Journal of Nuclear …, 1995 - europepmc.org
Methods After giving a 7.4 MBq 131I-OIH and 90-110 MBq 99mTc-EC or 99mTc-MAG3
bolus, a constant infusion (1MBq/ml 99mTc-agent and 0.07 MBq/m 131I-OIH was started …

Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine

GF Gates - Clinical nuclear medicine, 2004 - journals.lww.com
Purpose: Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were
determined in 92 patients to calculate filtration fraction (GFR/EFPR) and evaluate its change …

Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods

M Bocher, Y Shrem, A Tappiser, M Klein… - Clinical nuclear …, 2001 - journals.lww.com
Purpose To compare the accuracy of three camera-assisted methods for the measurement
of Tc-99m mercaptoacetyltriglycine (MAG3) clearance. Materials and Methods MAG3 renal …

Technetium-99m-MAG3 renal studies in spinal cord injury patients: normal range, reproducibility, and change as a function of duration and level of injury

WC Klingensmith III, DP Lammertse, DE Briggs… - Spinal Cord, 1996 - nature.com
The normal range, reproducibility, and change as a function of duration and level of injury for
Tc-99m-MAG3 renal studies were quantitated in spinal cord injury (SCI) patients …